AJP - Endo AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (June 24, 2003). doi:10.1152/ajpendo.00486.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/1/E129    most recent
00486.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Battezzati, A.
Right arrow Articles by Luzi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Battezzati, A.
Right arrow Articles by Luzi, L.
Submitted on November 7, 2002
Accepted on May 30, 2003

NON-HEPATIC GLUCOSE PRODUCTION IN HUMANS

Alberto Battezzati1*, Andrea Caumo2, Francesca Martino2, Lucia Piceni Sereni2, Jorgelina Coppa3, Raffaele Romito3, Mario Ammatuna3, Enrico Regalia3, Dwight E Matthews4, Vincenzo Mazzaferro3, and Livio Luzi2

1 International Center for the Assessment of Nutritional Status, DiSTAM, Universita' degli Studi di Milano, Milano, Milano, Italy; Department of Medicine, Istituto Scientifico H San Raffaele, Milano, Milano, Italy
2 Department of Medicine, Istituto Scientifico H San Raffaele, Milano, Milano, Italy
3 Liver Transplantation Unit, Istituto Nazionale dei Tumori, Milano, Milano, Italy
4 University of Vermont, Burlington, VT, USA

* To whom correspondence should be addressed. E-mail: battezzati.alberto{at}hsr.it.

Extrahepatic glucose release was evaluated during the anhepatic phase of liver transplantation in 14 recipients for localized hepatocarcinoma with mild or absent cirrhosis, who received a bolus of [6,6-2H2]glucose and L-[3-13C]alanine or L-[1,2-13C2]glutamine to measure glucose kinetics and to prove whether gluconeogenesis occurred from alanine and glutamine. Twelve were studied again 7 months thereafter with 7 healthy subjects. At the beginning of the anhepatic phase plasma glucose was increased and then declined by 15% per hour. The right kidney released glucose, with an arterial-venous gradient of -3.7 mg/dl. Arterial and portal glucose concentrations were similar. The glucose clearance was 25% reduced but glucose uptake was similar to the control groups. Glucose production was 9.5±0.9 µmol/kg/min, 30% less than in controls. Glucose became enriched with 13C from alanine and especially glutamine, proving the extrahepatic gluconeogenesis. The gluconeogenic precursors alanine, glutamine, lactate, pyruvate and glycerol, insulin and the counterregulatory hormones epinephrine, cortisol, growth hormone and glucagon were several-fold increased. Extrahepatic organs synthesize glucose at a rate similar to postabsorptive healthy subjects when the hepatic production is absent, and gluconeogenic precursors and counterregulatory hormones are markedly increased. The kidney is the main but probably not the unique source of the extrahepatic glucose production.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
B. Becker, F. Kronenberg, J. T. Kielstein, H. Haller, C. Morath, E. Ritz, D. Fliser, and for the MMKD Study Group
Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study
J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1091 - 1098.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.